By Appbay Technologies
Growth alone doesn’t answer the question that was asked.
A Qatari Islamic bank named revenue diversification via digital platforms as its direct response to a stated concentration risk challenge – a clear, logical strategy. New revenue is easy to report. Whether that revenue is actually reducing concentration, or just adding volume inside the same risk exposure, is a much harder number to produce.
This piece is a candid one – the fit here is a real analytical build, not a simple configuration, and we’d rather say that plainly than force a confident pitch.
The Priority: Diversification, Named as the Answer to Concentration Risk
Naming revenue diversification directly alongside a stated concentration risk challenge – rather than diversification as a vague growth aspiration – implies a clear, measurable link between the two. That’s a genuinely reasonable strategic logic on its own terms.
But it also invites an obvious board question: is the new revenue actually reducing concentration, or just adding volume inside the same risk profile? Naming the two together as strategy means proving one is actually moving the other, not just growing alongside it.
The Hidden Problem: Two Metrics, No Shared View
Here’s where the operational gap actually shows up, inside most banks pursuing digital-platform diversification as a response to concentration risk:
Two metrics, two owners – revenue growth sits with strategy/CFO; concentration risk sits with risk management, tracked separately No correlation view – there’s no single workflow showing whether new revenue streams sit inside or outside the bank’s existing risk concentration Growth reported, risk assumed – new platforms generate reportable revenue, but nobody is cross-checking it against the concentration metric it was meant to move The link stated, not measured – diversification and concentration risk were named together in strategy; they aren’t yet tracked together in practice
Why does this exist? The bank’s own stated challenge (concentration risk) directly motivates its stated priority (revenue diversification) – but naming the two together as strategy doesn’t automatically produce a system that measures one against the other. Proving the link requires comparing revenue data and risk data on the same terms, and most banks simply don’t have a system built to do that yet.
Why This Matters Now
The diversification strategy is funded and running. The board currently has no shared data linking new revenue to the concentration metric it was meant to move. This isn’t a hypothetical future concern – it’s the exact position the risk committee is in right now, review cycle after review cycle.
The board’s question isn’t whether diversification was the right call. It’s sharper than that:
“The concentration number was the target. Has it actually moved – or has revenue simply grown around it?”
For the CFO or Head of Strategy, this plays out as a live evidence problem, measured against metrics that don’t currently share a common view:
Concentration risk trend – is the metric actually moving, in the direction the strategy was meant to produce? Time-to-diversification-evidence – how long does it take to produce proof the strategy is working, today? Revenue-to-risk correlation – can any single revenue stream be shown to reduce concentration specifically, not just add volume?
Naming diversification as the answer to concentration risk isn’t the problem. Not being able to prove it worked is.
An Honest Look at the Fit
We want to say this plainly: this is a genuine partial fit, not a clean product match. This sits closer to a cross-metric analytical build than a standard compliance workflow – and while Appbay’s core strength is in regulated operational workflows like AML, KYC, and lending, this specific ask (correlating revenue data against risk concentration metrics, continuously) is a real, non-trivial build.
Where there’s a genuine, if partial, fit: our Multi-Perspective Document Insight Copilot and Master Compliance Copilot both transfer core capability – extracting data, comparing against criteria, summarizing for different audiences. But linking revenue diversification data directly to concentration risk metrics, on an ongoing basis, is new configuration work, not a repurposed product.
Here’s what that would actually involve, in principle:
- New Revenue Stream Data Ingestion Digital-platform revenue data brought into one place, rather than tracked separately from risk data with no shared reference point.
- AI-Driven Correlation Analysis Testing new revenue against concentration risk metrics directly, not just reporting the two side by side.
- Risk-Impact Analysis Showing whether a given revenue stream genuinely sits outside the existing concentration, or simply adds volume within it.
- Strategy/Risk Review People interpreting what the correlation actually means for the board’s next diversification decision.
- Appian-Orchestrated Reporting Workflow and Audit Trail One governed process producing the evidence on a repeatable basis, not a one-time analysis that goes stale by the next review.
This is a real build, worth a candid conversation about scope – not a quick proof-of-concept promise dressed up as a sure thing, though a scoped pilot on one revenue stream is a reasonable way to start that conversation.
Why We’re Saying This Plainly
Being upfront matters more here than a confident pitch would. This particular evidence gap is real and worth solving, but it sits closer to a cross-metric analytics problem than most of what we write about. The honest starting point is naming that clearly, rather than stretching an existing product to fit a problem it wasn’t specifically built for.
This Pattern Isn’t Unique to One Bank
Any institution naming revenue diversification as its direct response to a concentration risk challenge will eventually face the same board question: did it actually work? The banks getting ahead of this aren’t assuming an existing dashboard already answers it. They’re being honest about what building real evidence would take.
Let’s Compare Notes
We’re working with banks across the GCC linking revenue diversification directly to concentration risk reduction – same evidence gap. If your organization is facing a similar measurement gap, we’d welcome the conversation.
Send us a message – this one’s genuinely about comparing notes, not a pitch.
